Marburg, Germany

Ernst-Guenter Afting

This inventor holds 2 USPTO granted patents. Top assignees: Chiron Corporation, Behringwerke Aktiengesellschaft, Hoechst Marion Roussel Deutschland Gmbh. Active years: 1997-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ernst-Guenter Afting. Retrieved from https://idiyas.com/inventor/ernst-guenter-afting

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1997-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Ernst-Guenter Afting

Introduction

Ernst-Guenter Afting is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of peptide plasminogen activators. With a total of two patents to his name, Afting's work has advanced the understanding and application of tissue plasminogen activator (tPA).

Latest Patents

Afting's latest patents focus on novel polypeptide compositions derived from the amino acid sequence of tissue plasminogen activator. These innovations provide improved properties over natural tPA, including enhanced specific activity and reduced response to inhibition by plasminogen activator inhibitors. His work also emphasizes modifications to the N- or C-termini of the polypeptides, which lead to reduced fibrin stimulation of plasminogenolytic activity and enhanced affinity to fibrin surfaces.

Career Highlights

Throughout his career, Afting has worked with prominent companies in the biotechnology sector. He has been associated with Chiron Corporation and Behringwerke Aktiengesellschaft, where he contributed to various research and development projects. His expertise in peptide technology has positioned him as a valuable asset in the field.

Collaborations

Afting has collaborated with notable professionals in his field, including Nancy L. Haigwood and Guy T. Mullenbach. These collaborations have further enriched his research and have led to advancements in the understanding of plasminogen activators.

Conclusion

Ernst-Guenter Afting's contributions to the field of biochemistry, particularly through his patents on peptide plasminogen activators, highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the development of therapeutic agents that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…